NCT00013650View on ClinicalTrials.gov

Effects of an Anti-Inflammatory Drug in Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 22, 2001

Study Completion Date

April 21, 2008

Conditions
Alzheimer's Disease
Interventions
DRUG

Cyclophosphamate

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH

NCT00013650 - Effects of an Anti-Inflammatory Drug in Alzheimer's Disease | Biotech Hunter | Biotech Hunter